| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d452ebbe234b18c80d0462dc24578da3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-988
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y205-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y404-01001
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-285
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y208-01002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-91194 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1085
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6896 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-10 |
| filingDate |
2021-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0182c4398295a773c0c07635ebc34227
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e2dd134c30cc05ad3deb06c5da48bcf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f951edea307f5d95bed3b0f9ff65afe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_edad9597d64978c6992fec821e365263
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce9dedb1c90de3f9b7e93125c5c9d057
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f63c10e1950722c9d9b2847d1c3ce7cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9cbe9e30e42f0db0cc9d9b7cd2815981 |
| publicationDate |
2022-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2022163541-A1 |
| titleOfInvention |
Methods of diagnosing and treating multiple sclerosis with vascular endothelial biomarkers |
| abstract |
The presently disclosed invention relates to a method of diagnosing Multiple Sclerosis (MS) in a patient comprising obtaining a sample from the patient, determining a level of one or more H2S generating enzymes in the sample from the patient, and diagnosing the patient with MS when the level of the one or more H2S generating enzymes is one of at least 15% higher or lower than a control level for the one or more H2S generating enzymes, and at least 10% higher or lower than a control level for the one or more H2S generating enzymes. |
| priorityDate |
2020-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |